preformulation

In preparation for the 8th Annual Improving Solubility Summit, taking place in June, Pharma IQ would like to invite you to take part in a short survey. The survey consists of no more than 8 questions...

As part of the Pharma Leaders Today Series Dr. Keith Horspool, Vice President, Pharmaceutical Development US, Boehringer Ingelheim, speaks to Andrea Charles from Pharma IQ, about why changes are...

Senior leaders from across the industry will meet at Pharma IQ's Global Pre-Formulation and Formulation Summit in Amsterdam this April to discuss latest developments and challenges in the field. With...

What would you say are the main benefits of employing early formulation testing? Most small or virtual biopharm companies try to progress their asset as quickly as possible to a clinical decision mak...

David Elder, Externalisation Director for GlaxoSmithKline and Pharma IQ Advisory Board Member, joins Andrea Charles from Pharma IQ, to discuss the most critical unmet drug delivery need an...

  What are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook now to find out! Rene Holm, Head of Preformulation at H L...

What strategies are pharmaceutical companies employing to accelerate early development and preformulation? Michael Mitchell, Head of Pharmaceutical Sciences Oss, Merck, speaks to Andrea Charles from...

Dr. Per Holm, Chief Specialist Product Development and Lifecycle Lundbeck, joined Pharma IQ for a quick Q&A session on formulation development ahead of the Global Preformulation & Fo...

With the advent of improved techniques for drug discovery, there has been a transition towards new chemical entities to be hydrophobic and non-polar, which in turn has made solubilization of these e...